Bioxcel Therapeutics Logo

Innovative Medicine Backed by the Power of AI

BioXcel Therapeutics, Inc. is a
biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches.

Innovative Medicine
Backed by the
Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Innovative Medicine
Backed by the Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Our Approach to Drug Development

AI-based Drug Development

Our neuroscience and immuno-oncology franchises utilize our AI
approach to drug identification and development

Neuroscience

BXCL501-Neuroscience-image

Immuno-Oncology

BXCL701-Immuno-Oncology-image

Latest News

Mar 14, 2023
OnkosXcel Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public OfferingVIEW RELEASE
Mar 09, 2023
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational HighlightsVIEW RELEASE
Feb 23, 2023
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023VIEW RELEASE

Stock Information

BioXcel Therapeutics, Inc.

Mar 30, 2023 04:00 PM

MARKET/SYMBOL

Nasdaq:

BTAI

PRICE

18.6

CHANGE

0.52 (0%)